Meristem Family Wealth, LLC Novartis Ag Transaction History

Meristem Family Wealth, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $190,646 - $211,211	-2,321 Closed	0 $0
Q2 2020 Aug 06, 2020	BUY	$80.93 - $91.1 $187,838 - $211,443	2,321 New	2,321 $203,000
Q1 2020 May 12, 2020	SELL	$70.67 - $99.01 $168,265 - $235,742	-2,381 Closed	0 $0
Q4 2019 Jan 31, 2020	SELL	$84.35 - $95.37 $5,904 - $6,675	-70 Reduced 2.86%	2,381 $225,000
Q3 2019 Nov 08, 2019	BUY	$85.54 - $94.26 $209,658 - $231,031	2,451 New	2,451 $213,000
Q3 2018 Nov 20, 2018	SELL	$66.94 - $77.43 $192,519 - $222,688	-2,876 Closed	0 $0
Q2 2018 Aug 09, 2018	SELL	$64.91 - $73.36 $3,050 - $3,447	-47 Reduced 1.61%	2,876 $217,000
Q1 2018 May 14, 2018	BUY	$70.39 - $84.15 $205,749 - $245,970	2,923 New	2,923 $236,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Meristem Family Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Meristem Family Wealth, LLC with notifications on news.